CINECA IRIS Institutional Research Information System

VALDISERRA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.610
AS - Asia 1.411
EU - Europa 1.075
SA - Sud America 198
AF - Africa 99
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.417
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.560
SG - Singapore 488
IT - Italia 331
CN - Cina 307
SE - Svezia 179
HK - Hong Kong 169
BR - Brasile 155
IN - India 116
DE - Germania 113
VN - Vietnam 111
GB - Regno Unito 102
FI - Finlandia 82
FR - Francia 69
JP - Giappone 63
NL - Olanda 43
CI - Costa d'Avorio 38
BG - Bulgaria 33
TR - Turchia 27
KR - Corea 26
CA - Canada 23
PL - Polonia 20
RU - Federazione Russa 20
AU - Australia 19
AT - Austria 17
MX - Messico 15
SN - Senegal 15
BD - Bangladesh 14
AR - Argentina 13
ID - Indonesia 13
IQ - Iraq 11
NG - Nigeria 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
IR - Iran 9
LT - Lituania 9
MA - Marocco 9
PT - Portogallo 9
SA - Arabia Saudita 9
UZ - Uzbekistan 8
ES - Italia 7
PK - Pakistan 7
VE - Venezuela 7
EC - Ecuador 6
PE - Perù 6
UA - Ucraina 6
EG - Egitto 5
XK - ???statistics.table.value.countryCode.XK??? 5
CH - Svizzera 4
CL - Cile 4
IE - Irlanda 4
JO - Giordania 4
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
IL - Israele 3
JM - Giamaica 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
AL - Albania 2
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GR - Grecia 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
PY - Paraguay 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JE - Jersey 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
RO - Romania 1
SI - Slovenia 1
SO - Somalia 1
TJ - Tagikistan 1
Totale 4.417
Salva come PNG Salva come JPEG
Città #
Singapore 283
Ashburn 278
San Jose 193
Dallas 177
Hong Kong 165
Santa Clara 159
Shanghai 94
Los Angeles 64
Munich 62
Boardman 58
Chandler 54
Florence 51
Beijing 46
London 41
Tokyo 41
New York 40
Pisa 40
Abidjan 38
Turku 38
Helsinki 35
Sofia 33
Ho Chi Minh City 29
Hanoi 27
Serra 27
Mumbai 26
Lauterbourg 21
Kent 20
Frankfurt am Main 19
Hyderabad 19
Massa 19
Princeton 19
Rome 19
Istanbul 18
Fairfield 17
Hefei 16
Dakar 15
Lawrence 15
Milan 13
Warsaw 13
Buffalo 12
Council Bluffs 12
Denver 12
Da Nang 11
Medford 11
Seoul 11
Chicago 10
Lagos 10
São Paulo 10
Wilmington 10
Amsterdam 9
Ogden 9
Redondo Beach 9
Atlanta 8
Bengaluru 8
Fuzhou 8
Jakarta 8
San Francisco 8
Tashkent 8
Washington 8
Chennai 7
Johannesburg 7
Livorno 7
Orem 7
Redwood City 7
Vienna 7
Houston 6
Jeju City 6
Lappeenranta 6
Phoenix 6
Poplar 6
Roubaix 6
Vancouver 6
Belo Horizonte 5
Brooklyn 5
Buenos Aires 5
Cambridge 5
Düsseldorf 5
Haiphong 5
Manchester 5
Marseille 5
Mexico City 5
Naples 5
New Malden 5
Nuremberg 5
Paris 5
Prague 5
Pristina 5
Quanzhou 5
Rio de Janeiro 5
Riyadh 5
Torres Vedras 5
Trujillo 5
Amman 4
Baltimore 4
Birmingham 4
Bremen 4
Cascina 4
Curitiba 4
Dublin 4
Kolkata 4
Totale 2.750
Salva come PNG Salva come JPEG
Nome #
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 195
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 177
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 174
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 173
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 159
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 150
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 148
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 144
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 141
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 140
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 138
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 133
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study 132
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 132
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 131
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 128
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 126
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 126
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 124
The pharmacological blockade of P2X4 receptor as a viable approach to manage visceral pain in a rat model of colitis 123
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 119
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 115
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 110
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 109
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 107
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 107
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 95
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 94
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 87
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 85
Communicating Drug Safety 83
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 79
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 78
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 76
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 73
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall 64
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 58
Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling 32
Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging 19
Totale 4.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.418
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 6 22
2021/2022328 4 2 54 60 55 24 15 12 15 9 22 56
2022/2023373 59 81 30 17 21 24 22 5 77 0 37 0
2023/2024407 3 11 23 3 30 46 58 36 32 26 67 72
2024/20251.574 34 64 85 132 99 159 159 58 160 171 186 267
2025/20261.774 163 137 216 189 208 105 300 69 170 189 28 0
Totale 4.484